PMC:7784830 / 8753-8849 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"166","span":{"begin":82,"end":90},"obj":"Species"},{"id":"180","span":{"begin":60,"end":81},"obj":"Disease"}],"attributes":[{"id":"A166","pred":"tao:has_database_id","subj":"166","obj":"Tax:9606"},{"id":"A180","pred":"tao:has_database_id","subj":"180","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"I-Mab Biopharma TJM2 – acts by neutralizing high GM-CSF in corona virus infected patients [49]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T75","span":{"begin":0,"end":96},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"I-Mab Biopharma TJM2 – acts by neutralizing high GM-CSF in corona virus infected patients [49]"}